Benzinga

Benzinga

Benzinga

mercredi, septembre 02

Icecure Medical Ltd

ICCMNASDAQ
Trade with Public
Trade with Public
$2.24
-0.04-1.75%
Dern. MÀJ: Sep 2, 9:28 AM
AperçuActualitésPrévisions de résultatsÉvénementsObjectifs de coursDonnées financièresSentimentComparerRapport sur les stocks

Icecure Medical Analyst Price Targets

Wall Street analyst price targets and consensus rating for Icecure Medical (ICCM).

Price Target Range — 11 Quarters

Analyst Consensus — 3 Analysts

3Buy
Consensus RatingBuy# Analysts3Avg. Consensus PT$2Upside to Avg. PT-4.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
May 14, 2026Maxim GroupAnthony VendettiPT CutBuy$3→$1
Oct 7, 2025HC Wainwright & Co.Yi ChenPT RaiseBuy$2→$3
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Maxim Group Maintains Buy on Icecure Medical, Lowers Price Target to $1

Maxim Group analyst Anthony Vendetti maintains Icecure Medical (NASDAQ:ICCM) with a Buy and lowers the price target from $3 to $1.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Icecure Medical, Raises Price Target to $2.5

HC Wainwright & Co. analyst Yi Chen maintains Icecure Medical (NASDAQ:ICCM) with a Buy and raises the price target from $2 to $2.5.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Icecure Medical, Lowers Price Target to $2

HC Wainwright & Co. analyst Yi Chen maintains Icecure Medical (NASDAQ:ICCM) with a Buy and lowers the price target from $2.5 to $2.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Icecure Medical, Maintains $2.5 Price Target

HC Wainwright & Co. analyst Yi Chen reiterates Icecure Medical (NASDAQ:ICCM) with a Buy and maintains $2.5 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Icecure Medical, Maintains $2.5 Price Target

HC Wainwright & Co. analyst Yi Chen reiterates Icecure Medical (NASDAQ:ICCM) with a Buy and maintains $2.5 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Icecure Medical, Maintains $2.5 Price Target

HC Wainwright & Co. analyst Yi Chen reiterates Icecure Medical (NASDAQ:ICCM) with a Buy and maintains $2.5 price target.
Benzinga Newsdesk

Données et API: API Benzinga · API d'actualités boursières · API de notations d'analystes · API de logo d'entreprise

Données de marché fournies par API Benzinga

Benzinga

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

© 2026 Benzinga | All Rights Reserved